The Biostatistics Core provides overall coordination of the Projects and Cores, and facilitates collaboration among investigators and staff. This is achieved through the efforts of the Core Director, Gerald L. DeNardo, M.D., Principal Investigator for the Program Project. This core includes a group of individuals selected to work with him in fulfilling these objectives with an economy of effort that could not be achieved by assignment of these resources to specific Projects and Cores. K. Lamborn, PhD, provides statistical support and scientific coordination in the design and analysis of laboratory preclinical and clinical studies. Additionally, as members of the Cancer Center, investigators have access to L. Beckett, PhD, Director of the Biostatistics Shared Resource for the Cancer Center and her group. The Program Management Officer is responsible for providing budgetary controls and information for investigators, assuring fiscal responsibility, and for interactions with administrative units within the program, University and NCl granting agency. The Laboratory Manager is responsible for all laboratory research activities conducted insupport of the program and assists with planning and coordination of studies, particularly those involving multiple investigators. The AA/Secretary provides secretarial support to the Program Project personnel, handling all manuscript/publication and grant typing, filing, and correspondence related to the Program Project grant. The personnel identified in this core provide the interfaces and support for members and units within the Program Project and between the Program Project and the community at large. These services are not otherwise available and this type of support has significantly contributed to the research accomplishments of the entire investigative team. Centralization of selected activities and personnel provides functional resilience in the face of limited resources. The increased geographic diversity of this Program Project will require continued and expanded efforts by the individuals in this core. Fortunately NCI designation for our Cancer Center provides a variety of opportunities for expanded support to the program.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
2P01CA047829-15A2
Application #
6989512
Study Section
Subcommittee G - Education (NCI)
Project Start
2004-04-01
Project End
2007-03-31
Budget Start
2004-04-01
Budget End
2005-03-31
Support Year
15
Fiscal Year
2004
Total Cost
$422,038
Indirect Cost
Name
University of California Davis
Department
Type
DUNS #
047120084
City
Davis
State
CA
Country
United States
Zip Code
95618
Schellinger, Joan G; Kudupudi, Avinash; Natarajan, Arutselvan et al. (2012) A general chemical synthesis platform for crosslinking multivalent single chain variable fragments. Org Biomol Chem 10:1521-6
Saludes, Jonel P; Natarajan, Arutselvan; DeNardo, Sally J et al. (2010) The remarkable stability of chimeric, sialic acid-derived alpha/delta-peptides in human blood plasma. Chem Biol Drug Des 75:455-60
Balhorn, Rod; Hok, Saphon; DeNardo, Sally et al. (2009) Hexa-arginine enhanced uptake and residualization of selective high affinity ligands by Raji lymphoma cells. Mol Cancer 8:25
Sulchek, Todd; Friddle, Raymond; Ratto, Timothy et al. (2009) Single-molecule approach to understanding multivalent binding kinetics. Ann N Y Acad Sci 1161:74-82
Kumaresan, Pappanaicken R; Luo, Juntao; Lam, Kit S (2009) On-demand cleavable linkers for radioimmunotherapy. Methods Mol Biol 539:191-211
DeNardo, G L; Mirick, G R; Hok, S et al. (2009) Molecular specific and cell selective cytotoxicity induced by a novel synthetic HLA-DR antibody mimic for lymphoma and leukemia. Int J Oncol 34:511-6
DeNardo, Gerald L; Natarajan, Arutselvan; Hok, Saphon et al. (2008) Nanomolecular HLA-DR10 antibody mimics: A potent system for molecular targeted therapy and imaging. Cancer Biother Radiopharm 23:783-96
Natarajan, Arutselvan; Xiong, Cheng-Yi; Gruettner, Cordula et al. (2008) Development of multivalent radioimmunonanoparticles for cancer imaging and therapy. Cancer Biother Radiopharm 23:82-91
Lehmann, Joerg; Natarajan, Arutselvan; Denardo, Gerald L et al. (2008) Short communication: nanoparticle thermotherapy and external beam radiation therapy for human prostate cancer cells. Cancer Biother Radiopharm 23:265-71
Kumaresan, Pappanaicken R; Luo, Juntao; Song, Aimin et al. (2008) Evaluation of ketone-oxime method for developing therapeutic on-demand cleavable immunoconjugates. Bioconjug Chem 19:1313-8

Showing the most recent 10 out of 187 publications